Grupo de fisiopatología y terapéutica neurológica del Instituto del Niño y del Adolescente (INA) del Hospital Clínico San Carlos
NEURO-INA-IN
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas
Madrid, EspañaPublicacions en col·laboració amb investigadors/es de Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (7)
2022
-
Regulation of Expression of Cannabinoid CB2 and Serotonin 5HT1A Receptor Complexes by Cannabinoids in Animal Models of Hypoxia and in Oxygen/Glucose-Deprived Neurons
International journal of molecular sciences, Vol. 23, Núm. 17
2019
-
Cannabidiol administration prevents hypoxia-ischemia-induced hypomyelination in newborn rats
Frontiers in Pharmacology, Vol. 10, Núm. SEP
2018
-
Cannabinoid signalling in the immature brain: Encephalopathies and neurodevelopmental disorders
Biochemical Pharmacology, Vol. 157, pp. 85-96
2015
-
Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications
Neurotherapeutics, Vol. 12, Núm. 4, pp. 793-806
2013
-
Cannabidiol for neurodegenerative disorders: Important new clinical applications for this phytocannabinoid?
British Journal of Clinical Pharmacology, Vol. 75, Núm. 2, pp. 323-333
2012
-
Cannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function
Neuropharmacology, Vol. 63, Núm. 5, pp. 776-783
2010
-
The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB2 and adenosine receptors
Neurobiology of Disease, Vol. 37, Núm. 2, pp. 434-440